Your Article Summary
See Latest ArticlesZidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy
AIDS, 01/08/08
Blumer R et al. - Treatment for 3 months with a NRTI-containing, but not a NRTI-sparing, regimen resulted in a 25% decrease in insulin-mediated glucose disposal and a 22% increase in fasting lipolysis. In the absence of discernable changes in body composition, NRTI may directly affect glucose metabolism, the mechanism by which remains to be elucidated
Related Articles
Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
BMC Infectious Diseases, 10/20/09
Relevance Score: 67%
Interleukin-2 Therapy in Patients with HIV Infection
New England Journal of Medicine, 10/15/09
Relevance Score: 67%
Epidemiology and therapy of pain and depression during HIV and AIDS
Schmerz, 10/01/09
Relevance Score: 67%
Association of Race, Substance Abuse, and Health Insurance Coverage With Use of Highly Active Antiretroviral Therapy Among HIV-Infected Women, 2005
American Journal of Public Health, 11/16/09
Relevance Score: 66%
Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine
Clinical Infectious Diseases, 10/28/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Psychoactive Medications and Falls
Geriatrics & Aging, 12/01/09
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Vascular Health and Risk Management, 12/01/09
Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09